This is a summary of the European public assessment report (EPAR). It explains how the Committee for Medicinal Products for Human Use (CHMP) assessed the studies performed, to reach its recommendations on how to use the medicine. If you need more information about your medical condition or your treatment, read the package leaflet (also part of the EPAR) or contact your doctor or pharmacist. If you want more information on the basis for the CHMP recommendations, read the scientific discussion (also part of the EPAR).
Therapeutic Indication
Treatment of symptomatic anaemia associated with chronic renal failure in adult patients. Treatment of symptomatic anaemia in adult cancer patients with non\-myeloid malignancies receiving chemotherapy.
Therapeutic Area (MeSH)
ATC Code
B03XA01
ATC Item
N/A
Pharmacotherapeutic Group
Other antianemic preparations
Active Substance (Summary)
INN / Common Names
EMA Name
Biopoin
Medicine Name
Biopoin
Aliases
N/ANo risk management plan link.
